Literature DB >> 28755152

Assisted reproduction and risk of preterm birth in singletons by infertility diagnoses and treatment modalities: a population-based study.

Galit Levi Dunietz1,2, Claudia Holzman3, Yujia Zhang4, Chenxi Li3, David Todem3, Sheree L Boulet4, Patricia McKane5, Dmitry M Kissin4, Glenn Copeland6, Dana Bernson7, Michael P Diamond8.   

Abstract

PURPOSE: The purpose of this study is to examine the spectrum of infertility diagnoses and assisted reproductive technology (ART) treatments in relation to risk of preterm birth (PTB) in singletons.
METHODS: Population-based assisted reproductive technology surveillance data for 2000-2010 were linked with birth certificates from three states: Florida, Massachusetts, and Michigan, resulting in a sample of 4,370,361 non-ART and 28,430 ART-related singletons. Logistic regression models with robust variance estimators were used to compare PTB risk among singletons conceived with and without ART, the former grouped by parental infertility diagnoses and treatment modalities. Demographic and pregnancy factors were included in adjusted analyses.
RESULTS: ART was associated with increased PTB risk across all infertility diagnosis groups and treatment types: for conventional ART, adjusted relative risks ranged from 1.4 (95% CI 1.0, 1.9) for male infertility to 2.4 (95% CI 1.8, 3.3) for tubal ligation. Adding intra-cytoplasmic sperm injection and/or assisted hatching to conventional ART treatment did not alter associated PTB risks. Singletons conceived by mothers without infertility diagnosis and with donor semen had an increased PTB risk relative to non-ART singletons.
CONCLUSIONS: PTB risk among ART singletons is increased within each treatment type and all underlying infertility diagnosis, including male infertility. Preterm birth in ART singletons may be attributed to parental infertility, ART treatments, or their combination.

Entities:  

Keywords:  Assisted hatching; Assisted reproductive technology; Donor oocytes or embryos; Infertility; Intra-cytoplasmic sperm injection; Preterm birth

Mesh:

Year:  2017        PMID: 28755152      PMCID: PMC5699984          DOI: 10.1007/s10815-017-1003-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  31 in total

1.  Infertility and preterm delivery, birthweight, and Caesarean section: a study within the Danish National Birth Cohort.

Authors:  Olga Basso; Donna D Baird
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

2.  Pregnancy outcome at extremely advanced maternal age.

Authors:  Yariv Yogev; Nir Melamed; Ron Bardin; Kinneret Tenenbaum-Gavish; Gadi Ben-Shitrit; Avi Ben-Haroush
Journal:  Am J Obstet Gynecol       Date:  2010-10-20       Impact factor: 8.661

3.  Delivery outcomes for nulliparous women at the extremes of maternal age - a cohort study.

Authors:  D A Vaughan; B J Cleary; D J Murphy
Journal:  BJOG       Date:  2013-06-12       Impact factor: 6.531

4.  Perinatal outcomes in 6,338 singletons born after intrauterine insemination in Denmark, 2007 to 2012: the influence of ovarian stimulation.

Authors:  Sara Sofia Malchau; Anne Loft; Anna-Karina Aaris Henningsen; Anders Nyboe Andersen; Anja Pinborg
Journal:  Fertil Steril       Date:  2014-07-23       Impact factor: 7.329

5.  Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment.

Authors:  Judy E Stern; Barbara Luke; Michael Tobias; Daksha Gopal; Mark D Hornstein; Hafsatou Diop
Journal:  Fertil Steril       Date:  2015-03-23       Impact factor: 7.329

Review 6.  Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis.

Authors:  Shilpi Pandey; Ashalatha Shetty; Mark Hamilton; Siladitya Bhattacharya; Abha Maheshwari
Journal:  Hum Reprod Update       Date:  2012-05-19       Impact factor: 15.610

7.  Assisted reproductive technology and the risk of preterm birth among primiparas.

Authors:  Galit Levi Dunietz; Claudia Holzman; Patricia McKane; Chenxi Li; Sheree L Boulet; David Todem; Dmitry M Kissin; Glenn Copeland; Dana Bernson; William M Sappenfield; Michael P Diamond
Journal:  Fertil Steril       Date:  2015-02-20       Impact factor: 7.329

8.  Outcomes of pregnancies achieved by donor egg in vitro fertilization--a comparison with standard in vitro fertilization pregnancies.

Authors:  Donna A Wiggins; Elliott Main
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

Review 9.  Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis.

Authors:  Carmen Messerlian; Laura Maclagan; Olga Basso
Journal:  Hum Reprod       Date:  2012-10-05       Impact factor: 6.918

10.  Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study.

Authors:  Sara S Malchau; Anne Loft; Elisabeth C Larsen; Anna-Karina Aaris Henningsen; Steen Rasmussen; Anders Nyboe Andersen; Anja Pinborg
Journal:  Fertil Steril       Date:  2013-03-07       Impact factor: 7.329

View more
  3 in total

1.  Association of adverse birth outcomes with in vitro fertilization after controlling infertility factors based on a singleton live birth cohort.

Authors:  Huiting Yu; Zhou Liang; Renzhi Cai; Shan Jin; Tian Xia; Chunfang Wang; Yanping Kuang
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.996

2.  Assisted Reproductive Technology Treatment, the Catalyst to Amplify the Effect of Maternal Infertility on Preterm Birth.

Authors:  Youzhen Zhang; Wei Zhou; Wanbing Feng; Jingmei Hu; Kuona Hu; Linlin Cui; Zi-Jiang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

3.  Prevalences and predictive factors of maternal trauma through 18 months after premature birth: A longitudinal, observational and descriptive study.

Authors:  Emilie Brunson; Aurore Thierry; Fabienne Ligier; Laurianne Vulliez-Coady; Alexandre Novo; Anne-Catherine Rolland; Julien Eutrope
Journal:  PLoS One       Date:  2021-02-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.